DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lefere S, Van de Velde F, Hoorens A. , et al.
Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease.
Hepatology 2019;
69 (03) 1087-1104
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.